Health Care Costs

Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma

Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma

By

In a systematic review, researchers explored the financial burden of treating grade 3 to 4 adverse events associated with melanoma and its treatment.

Healthcare Use, Economic Burden Greater With Cancer-Related Opioid-Induced Constipation

Healthcare Use, Economic Burden Greater With Cancer-Related Opioid-Induced Constipation

By

Use of opioids to manage cancer-related pain may have adverse effects of its own that can have a significant impact on healthcare use among patients with cancer.

Financial Toxicity Discussions an Unmet Need for Breast Cancer Patients

Financial Toxicity Discussions an Unmet Need for Breast Cancer Patients

By

Survey responses revealed that clinicians and patients do not agree on whether discussions regarding the impact of treatment on employment and/or financial status occur or are helpful.

Younger Patients, Higher Costs: The Changing Demographics of Cancer

Younger Patients, Higher Costs: The Changing Demographics of Cancer

By

This overview provides a snapshot of the shift in cancer care costs and age of patients, reviewing the 4 most commonly diagnosed cancers.

The Health Care Mortgage: Understanding the Complexities of Financial Toxicity

The Health Care Mortgage: Understanding the Complexities of Financial Toxicity

By

Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.

Intervention With Lay Health Workers Has Positive Effect on Cancer Patients' Experience

Intervention With Lay Health Workers Has Positive Effect on Cancer Patients' Experience

By

An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.

Patient-Provider Conversations Regarding Financial Impact of Cancer Therapy Lacking

Patient-Provider Conversations Regarding Financial Impact of Cancer Therapy Lacking

By

Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.

Palliative care consultation linked to reduced direct hospital costs

1. In this meta-analysis of available studies, early palliative care consultation (PCC) for patients admitted to hospital with serious illness was associated with a reduction in direct hospital costs for that admission. 2. The reduction in direct hospital costs was greater for those patients with a cancer diagnosis and for those with 4 or more []

Benefits of Early Palliative Care for Cancer Extend Beyond Clinical Care

Benefits of Early Palliative Care for Cancer Extend Beyond Clinical Care

By

A meta-analysis shows that earlier initiation of palliative care can effectively change patterns of care for patients with higher illness burden.

Breast Cancer Treatment-Related Financial Burden Greater for Black vs White Women

Breast Cancer Treatment-Related Financial Burden Greater for Black vs White Women

In a study that evaluated outcomes for younger, working age women with breast cancer, researchers identified differences in cancer-related financial adverse events in black women vs white women.

SEE-ACBT Method Improves Postsurgical Outcomes in Lung Cancer Resection

SEE-ACBT Method Improves Postsurgical Outcomes in Lung Cancer Resection

By

In a quasi-experimental pre-post study, researchers demonstrate the efficacy of the SEE-ACBT rehabilitation method on health-related and cost outcomes in patients with NSCLC who underwent curative lung resection.

Improved Access to Care Reported by Cancer Survivors

Improved Access to Care Reported by Cancer Survivors

In the 2010 to 2016 period, the proportion of survivors reporting delayed medical care decreased yearly.

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

By

At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.

Lower-Income Households Experienced Improved Health Costs After ACA Implementation

Lower-Income Households Experienced Improved Health Costs After ACA Implementation

By

The Affordable Care Act was linked to reduced cost burdens for middle to low-income households, study data indicate.

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

By

Researchers report on their findings of a retrospective study that compared pomalidomide plus dexamethasone vs dexamethasone alone in patients with relapsed/refractory multiple myeloma.

Better Postoperative Outcomes With RAMIE for Esophageal Cancer

Better Postoperative Outcomes With RAMIE for Esophageal Cancer

By

Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Multimodal screening is more expensive, but reduces ovarian cancer mortality, researchers found.

Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden

Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden

By

Recent study findings investigated the economic burden of patients with relapsed Ph-negative ALL, and the adverse events of special interest that are most likely to have the greatest impact. These findings were presented at ASH 2017.

Physical Examination Sufficient Work-up for Complaints of Breast Pain

Physical Examination Sufficient Work-up for Complaints of Breast Pain

By

A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.

Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors

Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors

By

A cross-sectional survey revealed the impact of symptoms and economic burden on quality of life for survivors of gastrointestinal cancer.

Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits

Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits

By

Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.

Cost of Care Significantly Increased With Carcinoid Syndrome in NETs

Cost of Care Significantly Increased With Carcinoid Syndrome in NETs

By

Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).

Median Cost of Cancer Drug Development is Approximately $648 Million

Median Cost of Cancer Drug Development is Approximately $648 Million

Total revenue from sales of 10 drugs was 67.0 billion, with total RD spending of 7.2 billion, researchers found.

Insured Patients with Cancer May Experience Financial Distress

Insured Patients with Cancer May Experience Financial Distress

By

Cancer treatment is far costlier than expected, even for patients with cancer who have health insurance coverage, with being underinsured causing in the most distress for patients.

Poll: Many Seniors Struggling With Drug Costs Don't Seek Help

Poll: Many Seniors Struggling With Drug Costs Don't Seek Help

Roughly half of older Americans experiencing difficulty paying for needed drugs did not talk to their physicians about the issue, poll shows.

Clinical Trials May Benefit Oncology Patients

Clinical Trials May Benefit Oncology Patients

By

Research on the effects of research demonstrated that oncology-related clinical trials provide measurable benefits in terms

New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer

New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer

By

Doses May Be Adjusted for Treating NSCLC Patients

Can Biosimilars Help Achieve the Goals of US Health Care Reform?

Can Biosimilars Help Achieve the Goals of US Health Care Reform?

[Cancer Management and Research] This research examines the pros and cons of the Affordable Care Act enactment and the possible beneficial role biosimilars may play in this environment.

Young Cancer Survivors More Often Have Cost-Related Nonadherence

Young Cancer Survivors More Often Have Cost-Related Nonadherence

Risk of nonadherence was lower for survivors reporting a usual source of care than those without

United States Leads in Income-Based Health Care Inequalities

United States Leads in Income-Based Health Care Inequalities

More public tolerance for health care inequalities has been observed in the United States than other countries.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs